PALM BEACH GARDENS, FL--(Marketwire - December 18, 2007) - Pegasus Pharmaceuticals/HeartView LLC (PINKSHEETS: PGUZ) today announced the successful completion of the testing protocol for the clinical study of the Company’s HeartVue 6S System screening device, conducted by Harvard University at Massachusetts General Hospital.
